| Detected | Trial | Change |
|---|---|---|
| 2026-08-04 | NCT06215326 Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung… |
Primary endpoint(s) modified |
| 2026-08-04 | NCT06215326 Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung… |
date change Primary completion pushed: 2025-12-31 -> 2026-12-31 |
| 2026-08-04 | NCT06215326 Short-term Effects of Preoperative Exercise in Moderate-to-high Perioperative Risk Lung… |
date change Completion pushed: 2026-12-31 -> 2027-07-31 |
| 2026-08-02 | NCT06525441 Dietary Protein Sources and Glycemic Variability |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT05244213 Neoadjuvant Immunotherapy in EGFR-mutant Localized NSCLC |
overall status: Active, Not Recruiting → Unknown |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-13 | NCT07763977 The Effects and Neural Mechanisms of Vitamin D and Iron-Immune Homeostasis on Inhibitory… | Enrolling by Invitation | |
| 2026-08-07 | NCT07752589 Microbiota in Neoadjuvant Chemoimmunotherapy for NSCLC | Not Yet Recruiting | |
| 2026-08-05 | NCT07746453 Universal STAR-T Cell Injection in Autoimmune Kidney Diseases | Not Yet Recruiting | |
| 2026-08-05 | NCT07748260 De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast | Phase 3 | Not Yet Recruiting |
| 2026-07-31 | NCT07738328 Terbinafine for CSA-AKI Prevention | Phase 2 | Not Yet Recruiting |
| 2026-07-27 | NCT07727122 Multicenter Prospective Validation of AI Models for Malignancy Risk Prediction in… | Not Yet Recruiting | |
| 2026-07-23 | NCT07722754 Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06506838 | Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft… | Soft Tissue Sarcoma | Recruiting |
| NCT06738992 | Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair | Mitral Valve Repair Surgery | Recruiting |
| NCT04381143 | ASPIrin in Reducing Events in Dialysis ( ASPIRED ) | CKD (Chronic Kidney Disease) Stage 5D | Recruiting |
| NCT06498050 | Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent… | Diabetic Macular Edema | Active, Not Recruiting |
| NCT06956157 | NAC for Treatment-Resistant OCD and Other Related Disorders | Obsessive Compulsive Disorder (OCD) | Active, Not Recruiting |
| NCT07483398 | RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease | Parkinson's Disease With Nociceptive Pain | Active, Not Recruiting |
| Phase 3 | |||
| NCT06533384 | PARPi or Capecitabine Combined With PD-1 Inhibitors as Adjuvant Therapy in High-risk TNBC | Triple-negative Breast Cancer | Recruiting |
| NCT07016126 | D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or… | NSCLC (Non-small Cell Lung Cancer) | Recruiting |
| NCT04946734 | Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine | PFO - Patent Foramen Ovale | Active, Not Recruiting |
| NCT07686796 | Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With… | Local Advanced Rectal Cancer | Not Yet Recruiting |
| NCT07748260 | De-escalation Neoadjuvant Therapy for Intermediate Risk HER2-positive Early Breast | HER2-positive Breast Cancer | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07410169 | Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced… | Breast Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT05800340 | Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC | Non-Small Cell Lung Cancer | Recruiting |
| NCT05954897 | Lenvatinib, Tislelizumab Combined With RALOX Regimen HAIC in Advanced Hepatocellular… | Hepatocellular Carcinoma | Recruiting |
| NCT06102824 | Organoid-based Functional Precision Therapy for Advanced Breast Cancer | HER2-negative Breast Cancer | Recruiting |
| NCT06734182 | Neoadjuvant Envafolimab Plus Disitamab Vedotin and Carboplatin in Resectable HER2-Mutant… | Non-small Cell Lung Cancer | Recruiting |
| NCT06911606 | Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small… | SCLC, Limited Stage | Recruiting |
| NCT05272696 | Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06451861 | Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or… | Acute Myeloid Leukemia | Recruiting |
| NCT06391905 | PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of… | Colorectal Cancer | Not Yet Recruiting |
| NCT06547476 | Chidamide and PD-1 Inhibitor Plus Anlotinib for HER2-low Breast Cancer That Has Spread or… | Breast Cancer | Not Yet Recruiting |
| NCT07257575 | A Randomized Controlled Study of Serplulimab Combined With Chemotherapy for Locally… | Gastric Cancer Stage III | Active, Not Recruiting |
| NCT05740943 | Induction Lorlatinib in Stage III Non-small Cell Lung Cancer | Stage III NSCLC | Active, Not Recruiting |
| NCT07472478 | Phase II Neoadjuvant Study of Garsorasib Followed by Ivonescimab Plus Chemotherapy in… | Lung Cancer (NSCLC) | Not Yet Recruiting |
| NCT07486310 | Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC… | Advanced Gastric Cancer | Not Yet Recruiting |